Shupeng Liu

8PUBLICATIONS
12CO-AUTHORS
Molecular targetsNanomaterialsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 28, 2026
Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide.

|Jun 12, 2024
Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing.

Yaoqi Sun, Bing Xiong, Xueqian Shuai

|Feb 25, 2023
Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.

Jinye Ding, Chunyan Wang, Yaoqi Sun

|Oct 28, 2022
MCM2 in human cancer: functions, mechanisms, and clinical significance.

Yaoqi Sun, Zhongping Cheng, Shupeng Liu

|Jul 18, 2022
The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma.

Cunzhen Zhang, Lei Lu, Haibei Xin

|May 10, 2022
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites.

Ning Luo, Zubaidan Sulaiman, Chunyan Wang

Pageof 2

Frequent Collaborators

2 joint publications

Zhiwen Ding

1 joint publications

Yaoqi Sun

1 joint publications

Zhongping Cheng

1 joint publications

Cunzhen Zhang